Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects Publisher Pubmed

Rezaeimanesh N¹ ; Sahraian MA¹ ; Moghadasi AN¹ ; Eskandarieh S¹

Show Affiliations

1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Neurological Sciences Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Environmental Risk Factors in Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Acta Neurologica Belgica (2018)

2. Stressful Life Events, Socioeconomic Status, and the Risk of Neuromyelitis Optica Spectrum Disorder: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2020)

3. Efficacy and Safety of Rituximab in Patients With Refractory Neuromyelitis Optica Spectrum Disorders: A Prospective Observation in Iranian Cases, Caspian Journal of Internal Medicine (2020)

4. Environmental and Genetic Risk Factors in the Development of Neuromyelitis Optica, Expert Review of Ophthalmology (2020)

5. The Possible Beneficial Effects of Higher Vitamin B6 Intake From Diet on Cognitive Function of Patients With Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2020)

6. Whole Grains and Legumes Consumption in Association With Neuromyelitis Optica Spectrum Disorder Odds, Current Journal of Neurology (2021)

7. Microorganisms in Pathogenesis and Management of Neuromyelitis Optica Spectrum Disorder, Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases: Volume II: Kidney# Central Nervous System# Eye# Blood# Blood Vessels and Bowel (2023)

8. The Association Between Dietary Sugar Intake and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Multiple Sclerosis and Related Disorders (2019)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Sahraian (15)

Abdolreaza Naser Moghadasi (15)

Other Related Docs

9. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)

10. Lack of Attention to Epidemiological Study of Neuromyelitis Optica Spectrum Disorder Compared With That of Multiple Sclerosis in Iran, International Journal of MS Care (2019)

11. Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Series From Iran, Revue Neurologique (2022)

12. The Association Between Dietary Total Antioxidant Capacity and Nmo-Igg Seropositivity in Patients With Neuromyelitis Optica Spectrum Disorder, Clinical Neurology and Neurosurgery (2021)

13. The Association Between Body Mass Index, Demographic and Clinical Characteristics With Cognitive Performance in Patients With Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2022)

14. The Possible Role of Interleukin-6 As a Regulator of Insulin Sensitivity in Patients With Neuromyelitis Optica Spectrum Disorder, BMC Neurology (2021)

15. Sleep Disorders As a Possible Predisposing Attack Factor in Neuromyelitis Optica Spectrum Disorder (Nmosd): A Case-Control Study, Clinical Neurology and Neurosurgery (2021)

16. Increased Intracranial Pressure on a Patient With Neuromyelitis Optica Spectrum Disorder, Caspian Journal of Internal Medicine (2021)

17. Adding Erythropoietin to Intravenous Methylprednisolone in Acute Treatment of Attacks of Neuromyelitis Optica Spectrum Disorders: A Randomized Controlled Trial, Current Journal of Neurology (2022)

18. Neuromyelitis Optica Spectrum Disorders Registry System in Iran: Validity of Data Sets, Multiple Sclerosis and Related Disorders (2024)

19. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)

20. Dietary Total Antioxidant Capacity and Neuromyelitis Optica Spectrum Disorder Susceptibility, Nutrition and Food Science (2020)

Style	Citing Format
MLA	Rezaeimanesh N, et al.. "Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects." Neurological Sciences, vol. 41, no. 9, 2020, pp. 2647-2648.
APA	Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S (2020). Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects. Neurological Sciences, 41(9), 2647-2648.
Chicago	Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S. "Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects." Neurological Sciences 41, no. 9 (2020): 2647-2648.
Harvard	Rezaeimanesh N et al. (2020) 'Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects', Neurological Sciences, 41(9), pp. 2647-2648.
Vancouver	Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S. Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects. Neurological Sciences. 2020;41(9):2647-2648.
BibTex	@article{ author = {Rezaeimanesh N and Sahraian MA and Moghadasi AN and Eskandarieh S}, title = {Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects}, journal = {Neurological Sciences}, volume = {41}, number = {9}, pages = {2647-2648}, year = {2020} }
RIS	TY - JOUR AU - Rezaeimanesh N AU - Sahraian MA AU - Moghadasi AN AU - Eskandarieh S TI - Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects JO - Neurological Sciences VL - 41 IS - 9 SP - 2647 EP - 2648 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract